Part of Statistics in Pharmaceutical Development Using Quality-by-Design Approach a FDA Perspective

3385 days ago, 1869 views

PowerPoint PPT Presentation

2. Layout. FDA activities for qualityPharmaceutical CGMPs for the 21st CenturyONDQA\'s PQASThe craved stateQuality by outline (QbD) and configuration space (ICH Q8)Application of measurable instruments in QbDDesign of experimentsModel building

Presentation Transcript

Slide 1

<html> <head><title>403 Forbidden</title></head> <body> <h1>403 Forbidden</h1> <ul> <li>Code: AccessDenied</li> <li>Message: Access Denied</li> <li>RequestId: P2F6Y52JEZYRTP15</li> <li>HostId: knLTEgG1Qz4CGBEbiQuYKjkeuXnHgqGZZFOSZzcmp5W3Fzj8CV3nW9GMvbzam4hOhC1AeSWuTr4=</li> </ul> <hr/> </body> </html>

SPONSORS